GlaxoSmithKline Supports World Health Organization Efforts To Strengthen Global Pandemic Preparedness Plans
May 7th 2007Drug InformationBird Flu
GlaxoSmithKline [GSK: NYSE] today commended the commitment of the World Health Organization (WHO) to progress plans for ensuring that the world’s most vulnerable people are protected in the event of a pandemic. Key elements of that commitment include progress being made towards the development of an H5N1 vaccine global stockpile by the WHO, and efforts to establish an additional mechanism to ensure broader access to pandemic influenza vaccine for developing world countries. [click link for full article]
Read More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
